GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » EV-to-EBIT

Biohit Oyj (OHEL:BIOBV) EV-to-EBIT : 14.48 (As of May. 14, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biohit Oyj's Enterprise Value is €23.81 Mil. Biohit Oyj's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €1.65 Mil. Therefore, Biohit Oyj's EV-to-EBIT for today is 14.48.

The historical rank and industry rank for Biohit Oyj's EV-to-EBIT or its related term are showing as below:

OHEL:BIOBV' s EV-to-EBIT Range Over the Past 10 Years
Min: -43.94   Med: -15.26   Max: 23.07
Current: 14.48

During the past 13 years, the highest EV-to-EBIT of Biohit Oyj was 23.07. The lowest was -43.94. And the median was -15.26.

OHEL:BIOBV's EV-to-EBIT is ranked worse than
58.99% of 434 companies
in the Biotechnology industry
Industry Median: 9.44 vs OHEL:BIOBV: 14.48

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Biohit Oyj's Enterprise Value for the quarter that ended in Dec. 2023 was €22.38 Mil. Biohit Oyj's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €1.65 Mil. Biohit Oyj's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 7.35%.


Biohit Oyj EV-to-EBIT Historical Data

The historical data trend for Biohit Oyj's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj EV-to-EBIT Chart

Biohit Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.17 -9.74 -17.22 16.24 13.60

Biohit Oyj Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.22 - 16.24 - 13.60

Competitive Comparison of Biohit Oyj's EV-to-EBIT

For the Biotechnology subindustry, Biohit Oyj's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biohit Oyj's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biohit Oyj's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's EV-to-EBIT falls into.



Biohit Oyj EV-to-EBIT Calculation

Biohit Oyj's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=23.813/1.645
=14.48

Biohit Oyj's current Enterprise Value is €23.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biohit Oyj's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €1.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohit Oyj  (OHEL:BIOBV) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Biohit Oyj's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=1.645/22.377136
=7.35 %

Biohit Oyj's Enterprise Value for the quarter that ended in Dec. 2023 was €22.38 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biohit Oyj's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €1.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohit Oyj EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Biohit Oyj (OHEL:BIOBV) Business Description

Traded in Other Exchanges
N/A
Address
Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines